These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31827213)
21. MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation. Tang Y; Feng X; Lu Q; Cui C; Yu M; Wen Z; Luan Y; Dong L; Hu Z; Zhang R; Lu C; Liu J; Shinkura R; Hase K; Wang JY Mucosal Immunol; 2024 Jun; 17(3):450-460. PubMed ID: 38101774 [TBL] [Abstract][Full Text] [Related]
22. IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins. Xu X; Wu Y; Yi K; Hu Y; Ding W; Xing C Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907823 [TBL] [Abstract][Full Text] [Related]
23. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice. Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120 [TBL] [Abstract][Full Text] [Related]
24. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice. Kim YE; Lee M; Gu H; Kim J; Jeong S; Yeo S; Lee YJ; Im SH; Sung YC; Kim HJ; Weissman IL; Ahn GO Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29967068 [TBL] [Abstract][Full Text] [Related]
25. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. Uronis JM; Mühlbauer M; Herfarth HH; Rubinas TC; Jones GS; Jobin C PLoS One; 2009 Jun; 4(6):e6026. PubMed ID: 19551144 [TBL] [Abstract][Full Text] [Related]
26. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer. Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380 [TBL] [Abstract][Full Text] [Related]
27. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression. Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505 [No Abstract] [Full Text] [Related]
28. Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice. Grill JI; Neumann J; Ofner A; Marschall MK; Zierahn H; Herbst A; Wolf E; Kolligs FT Carcinogenesis; 2018 Sep; 39(9):1176-1184. PubMed ID: 29901779 [TBL] [Abstract][Full Text] [Related]
29. Increased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium-specific Deletion of Yang VW; Liu Y; Kim J; Shroyer KR; Bialkowska AB Mol Cancer Res; 2019 Jan; 17(1):165-176. PubMed ID: 30108164 [TBL] [Abstract][Full Text] [Related]
30. The germ-free mice monocolonization with Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742 [No Abstract] [Full Text] [Related]
31. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice. He J; Shin H; Wei X; Kadegowda AK; Chen R; Xie SK BMC Cancer; 2015 Mar; 15():189. PubMed ID: 25881076 [TBL] [Abstract][Full Text] [Related]
32. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice. Hammad A; Zheng ZH; Gao Y; Namani A; Shi HF; Tang X Life Sci; 2019 Dec; 238():116968. PubMed ID: 31628914 [TBL] [Abstract][Full Text] [Related]
33. Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice. Islam BN; Sharman SK; Hou Y; Bridges AE; Singh N; Kim S; Kolhe R; Trillo-Tinoco J; Rodriguez PC; Berger FG; Sridhar S; Browning DD Cancer Prev Res (Phila); 2017 Jul; 10(7):377-388. PubMed ID: 28468928 [TBL] [Abstract][Full Text] [Related]
34. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice. Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257 [TBL] [Abstract][Full Text] [Related]
35. Establishing the colitis-associated cancer progression mouse models. Zheng H; Lu Z; Wang R; Chen N; Zheng P Int J Immunopathol Pharmacol; 2016 Dec; 29(4):759-763. PubMed ID: 27694612 [TBL] [Abstract][Full Text] [Related]
36. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Das S; Rachagani S; Sheinin Y; Smith LM; Gurumurthy CB; Roy HK; Batra SK Oncogene; 2016 May; 35(20):2645-54. PubMed ID: 26364605 [TBL] [Abstract][Full Text] [Related]
37. Intestinal Epithelia and Myeloid Immune Cells Shape Colitis Severity and Colorectal Carcinogenesis via High-mobility Group Box Protein 1. Foelsch K; Pelczar P; Zierz E; Kondratowicz S; Qi M; Mueller C; Alawi M; Huebener S; Clauditz T; Gagliani N; Huber S; Huebener P J Crohns Colitis; 2024 Aug; 18(7):1122-1133. PubMed ID: 38285546 [TBL] [Abstract][Full Text] [Related]
38. Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators. Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070 [TBL] [Abstract][Full Text] [Related]
39. Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Williams BB; Tebbutt NC; Buchert M; Putoczki TL; Doggett K; Bao S; Johnstone CN; Masson F; Hollande F; Burgess AW; Scott AM; Ernst M; Heath JK Dis Model Mech; 2015 Aug; 8(8):805-15. PubMed ID: 26035389 [TBL] [Abstract][Full Text] [Related]
40. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development. Tian Y; Xu Q; Sun L; Ye Y; Ji G J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]